We recently succeeded in purifying a monocyte chemotactic factor (MCF) from the conditioned media of a myelomonocytic cell line (THP-1) (1). We have molecularly cloned the cDNA of MCF (2), and shown that MCF, in addition to its monocyte chemotactic activity, also activates monocytes to be more cytostatic against several types ofhuman tumor cells in vitro (1) . Therefore, we termed this molecule monocyte chemotactic and activating factor (MCAF). Subsequently, MCAF has been shown to be produced by several additional cell types, namely fibroblasts and endothelial cells (3) . We describe here that MCAF, which was purified from human fibrosarcoma cell line-conditioned media, also induces superoxide anion and lysosomal enzyme release from human monocytes and has potent in vivo monocyte recruitment activity.
Materials and MethodsPurification of MCAF. Confluent fibrosarcoma cells, 8387 (4), were stimulated with 100 ng/ml rTNF-a in serum-free media overnight. The culture supernatants were centrifuged, concentrated, and dialyzed against 0.05 M Tris-HCI, pH 7.5, before being applied to a 50-ml heparin Sepharose column . MCAF was eluted with 0.05 M Tris-HCI, pH 7.5, containing 0.5 M NaCl. The eluate was further concentrated and loaded on to a gel filtration column of Sephacryl S-200 (Pharmacia Fine Chemicals, Uppsala, Sweden), which was equilibrated with D-PBS. The fractions containing monocyte chemotaxis activity in the molecular mass range of 10-20 kD were pooled and then applied to a carboxymethyl-silica gel column (7.5 x 150-mm CM-3SW) (Toyo Soda, Tokyo, Japan) connected to an HPLC system (2150 ; LKB Instruments, Inc., Uppsala, Sweden) . The starting buffer was 0.02 M 3-[N-morpholino] propanesulfonic acid (MOPS), pH 6.5, and MCAF was eluted with a linear increase of salt concentration up to 0.5 M NaCl. Finally, samples were applied to a reverse phase chromatography column (4.6 x 750-mm TMS-250 Ultropac column, 10,m; Toyo Soda) with the starting